Supply Chain | April 27, 2022
Takeda awarded for Supply Chain and Pharma 4 at ISPE awards
Recognition illustrates Takeda’s patient-centricity throughout its manufacturing and supply processes
Recognition illustrates Takeda’s patient-centricity throughout its manufacturing and supply processes
New kit enhances menu of FFPE solutions and allows oncology researchers to extract higher yields of concentrated DNA compared to traditional techniques
Both companies have been selected for stand-by production by German government
If authorized by the USFDA, the Proof Lab Test System may be used to deliver accurate, actionable, lab-quality results for Covid-19 in as little as 18 minutes
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
The plant is scheduled to come on stream in September 2024
A novel second-generation approach to achieve a safe, durable, and stable transgene expression to overcome the challenges of factor VIII replacement therapies
Vela Analytics can create concise, evidence-based in-house reports that help customers with the information to make timely, informed decisions about possible treatment options
The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial
Subscribe To Our Newsletter & Stay Updated
